FDA Approves Qiagen’s Therascreen Urothelial Cancer Companion Diagnostic

The Therascreen FGFR kit helps identify urothelial tumors with alterations to the fibroblast growth factor receptor 3 gene that indicate...

      

Related Stories

• De Novo Anesthesia Device Placed In Class II
• There's A Pediatric Air-Tube Shortage Because A Sterilization Facility Was Shut Down
• Global Device Approvals Snapshot: April 9-15, 2019